Adjusted EBITDA increased by 188% YoY to ₹60 crore compared to ₹21 crore in the previous year, showing a good improvement in profitability.
EBITDA grew 48% YoY at ₹210 crore, from ₹142 crore in the same quarter last year, marking better profitability.
Revenue grew 7% year over year to ₹3,255 crore, as compared with ₹3,043 crore during the same quarter of last fiscal year
Revenue from operations was at ₹34,253.52 crore, which was 8% QoQ growth on the back of higher gas demand, against ₹31,822.62 crore in the preceding quarter
The currency has been under pressure, thus stabilizing it involves injecting Rs 600 billion into banks
The company’s revenue for the quarter registered an increase of 116% y-o-y to ₹3,457 Crore as compared to ₹1,596 Crore.
The sector is also looking for greater investment in EV charging stations and energy storage systems, which are necessary for a smoother transition to green mobility.
Biocon's EBITDA increased by 16% YoY to ₹787 crore, which shows improved operational performance.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
Top gainers in Nifty include Tata Cons. Prod (6%), Nestle (5.37%), Bharat Elec (5.09%), Trent (4.8%).

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.